Corneal stroma can clear LASIK contamination

Article

The corneal stroma has the ability to clear microorganisms introduced during LASIK.

The corneal stroma has the ability to clear microorganisms introduced during LASIK, according to a study published in the October issue of the Journal of Cataract and Refractive Surgery.

Sepehr Feizi and colleagues from Labbafinejad Hospital, Shaheed Beheshti University and Baqyatallah Hospital, Tehran, Iran measured the rate of corneal interface contamination during LASIK to determine possible sources of contamination and evaluate how the cornea reacts.

A total of 200 eyes were evaluated for corneal interface contamination following LASIK. Cultures were taken from the upper and lower eyelid margins and the inferior fornices prior to surgery and from the corneal interface and the instrument at the end of surgery. Media were cultured for 14 days at 37°C under aerobic and anaerobic conditions.

The rate of contamination was recorded as 24.5%. The most commonly found organism was Staphylococcus epidermidis, which was found in 43 cases (87.7%). None of the contaminated or non-contaminated cases developed corneal ulcers, however, two eyes did develop diffuse lamellar keratitis.

The authors concluded that the corneal stroma is able to clear LASIK induced microorganisms.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
© 2025 MJH Life Sciences

All rights reserved.